It is no surprise that many people have a fear of cancer extending from having it themselves to others close to them having it. When, therefore, a friend or family member comes home from the doctor one day with not just the C word but the incurable, advanced form: metastatic cancer, it’s sometimes difficult, if

... gemcitabine is not defined. 5fu with or without leukovorin, or Xeloda alone are often used to salvage pancreatic cancer patients who progress on gemcitabine. There is an active trial:  Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas. This study is ongoing, but not recruiting participants, NCT00003029. It is a ...

... occur and affect genes that do induce excessive proliferation. Metastatic cancer eventually results, regardless of whether the first harmful mutations occur in ... also pretty common, so we just have to deal with it. In fact, the complexity of processes associated with cancer (and much other biology as well) is an important lesson in all of this. Let's first consider the process of inflammation ...

... England about 30 years earlier. She developed cancer of the breast and had been told by doctors in Toronto that her case ... tea made from the herbs every day. Her breast cancer went into remission. Cassie was impressed, but did not do anything until a few months later when she received ... phagocytosis, the process by which the immune system can destroy metastatic cancer cells before they “glue” ...

... may return even after surgery, radiation therapy, and chemotherapy. Metastatic disease requires treatment of the original tumor site ... brain tumors respond to certain forms of therapy better than others. Metastatic brain tumors are classified depending on the exact ... years later. With control of intracranial disease, advances in cancer therapy will prolong survival, since most patients now succumb ...

... of patients over 50 years at diagnosis. Kidney cancer is twice as common in men than in women. (sex ratio 2 ... expanded gradually. Medical treatment of kidney cancer If the metastatic treatment has long been limited to immunotherapy ... metastases in some patients. However, the benefit of nephrectomy in patients with metastatic never been compared to antiangiogenic treatment. Thus, a European trial ...

... shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, ... women, who had breast tumors for an average of three years, had cancer that had metastasized, or spread to other parts of the body. They had been treated ... DM1 will perform even better in women with earlier-stage cancer, he adds. The study was funded by Genentech and Hoffmann ...

Gotta love a new breast cancer breakthrough. This one just in: “A new targeted cancer drug has been shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, failed,” says Charlene Laino for WebMD. The new drug is called T-DM1. The T stands for trastuzumab (that’s scientific

... company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from ... and stimulating the immune system to destroy un-injected metastatic deposits. Both modes of action have been clearly validated in the clinic, ... few side effects and even low rates of success against metastatic cancer are a big deal. The success rate will ...

... proportion of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterised by overexpression of the protein Mdm2. Lindsey Mayo and ... drives this increased Mdm2 expression and found that Mdm2 helps promote cancer cells take on more aggressive characteristics, making it a potential target for drugs to treat late-stage metastatic breast cancer...

... a FDA decision that is expected by May 2010 for its prostate cancer vaccine, Provenge, which is poised to become the first active cellular ... week in the form of a pact with Auburn to develop a cancer immunotherapy product for use in animals. The BioMedReports.com research ... women who have been diagnosed with Stage IV / Metastatic Breast Cancer and the treatment is free to eligible participants. ...

SAN ANTONIO, TX -- A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher. ...

... tumours, lymphomas and sarcomas. Surgical specimen of colon cancer with polyps The risk factors include: - older age - ... and extent of the disease. The mainstay of treatment for colon cancer is surgery. The type of surgery will depend on the site of ... cetuximab.    Patients who present with metastatic disease (stage 4) will usually be treated with palliative and ...

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its wholly-owned subsidiary, BiPar Sciences, announced that the clinical development program in metastatic triple-negative breast cancer (mTNBC) for the investigational PARP1 inhibitor, BSI-201, progresses as planned with the Phase 3 study meeting expectations on patient accrual and trial site coverage in the United States...

Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN) announced the preliminary results of a phase I trial in metastatic breast cancer with BN83495, Ipsen’s lead and first-in-class orally available irreversible steroid sulfatase (STS) inhibitor. In the course of the study, the optimal biological dose was determined as 40 mg once daily ...